Ligand Pharmaceuticals Incorporated · NASDAQ:LGND
Sabba Stephen L sold 2,145 Ligand Pharmaceuticals Incorporated shares (Form 4)
Traded Jun 16, 2026 · Filed Jun 18, 2026
On Jun 16, 2026, Sabba Stephen L (Director) sold 2,145 Ligand Pharmaceuticals Incorporated shares at US$254.00 for US$545K, leaving 33,629 shares. Filed Jun 18, 2026 (Form 4).
- Sold
- 2,145 shares
- Price
- US$254.00
- Value
- US$545K
- Holding after
- 33,629 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | Common Stock | Option exercise | 2,145 | US$66.13 | 35,774 | Direct |
| Jun 16, 2026 | Common Stock | Sale | 2,145 | US$254.00 | 33,629 | Direct |
Source
Related
- Ligand Pharmaceuticals Incorporated
- Sabba Stephen L
- Ligand Pharmaceuticals Incorporated shareholders
- Form 4 · Sabba Stephen L · Jun 9, 2026
- Form 4 · Reardon Andrew · Oct 6, 2026
- Form 4 · Zimmermann Martine · Sep 24, 2026
- Form 4 · Zimmermann Martine · Sep 14, 2026
- Form 4 · Reardon Andrew · Sep 8, 2026
- Form 4 · Espinoza Octavio · Aug 14, 2026